Biggest News Aggregation in the World
📰 Boxed Warning News

Page 8 - Boxed Warning News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Boxed Warning. Real-time updates on events, politics, business and more.

Merck's KEYTRUDA® (pembrolizumab) Reduced the Risk of Death by 38% Versus Placebo as Adjuvant Therapy for Patients With Renal Cell Carcinoma (RCC) at an Increased Risk of Recurrence Following Nephrectomy -January 27, 2024 at 10:01 am EST

KEYNOTE-564 is the first Phase 3 trial to demonstrate superior overall survival with adjuvant therapy compared to placebo in patients with RCC Late-breaking OS results selected for the official...
United States Tonik Choueiri Nancy Kohlberg Harvard Medical School Exchange Commission Asco Gu Press Program

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science